Skip to main content

Table 1 Visits and procedures to be performed

From: Study CAMBIMED: Effects of changes in medication appearance on safety of antihypertensive and hypolipidemic treatments in chronic patients older than 65 years in primary health care

 

Visit 1 Screening (0 months)

Visit 2 (3 months)

Visit 3 (6 months)

Visit 4 (9 months)

Visit 5 (12 months)

Recruitment following the selection criteria

X

    

Informed consent

X

    

Initial collection clinical information and sociodemographic data

X

    

BP control

X

X

X

X

X

Lipid profile control

X

 

X

 

X

Counting of drug packages

 

X

X

X

X

Morisky-Green test

X

X

X

X

X

Data collection for errors and adverse effects

 

X

X

X

X

Collection of followed-up clinical variables

 

X

X

X

X